Clinical correlates and cognitive associations of the neutrophil-to-lymphocyte ratio in first-episode psychosis and at-risk mental states - Report - MDSpire

Clinical correlates and cognitive associations of the neutrophil-to-lymphocyte ratio in first-episode psychosis and at-risk mental states

  • By

  • Clàudia Aymerich

  • Borja Pedruzo

  • Garazi Acasuso

  • Olatz Ibarretxe

  • Daniel Alonso-Alconada

  • Javier Labad

  • Maria José Algora

  • Ángel Cabezas

  • Gonzalo Salazar de Pablo

  • Miguel Ángel González-Torres

  • Vanessa Sanchez-Gistau

  • Ana Catalán

  • June 2, 2026

  • 0 min

Share

Clinical Report: Associations Between Neutrophil-to-Lymphocyte Ratio and Cognitive Function

Overview

This study examines the neutrophil-to-lymphocyte ratio (NLR) in individuals with first-episode psychosis (FEP), clinical high-risk for psychosis (CHR-P), and healthy controls. No significant differences in NLR were found among the groups.

Background

Understanding immune alterations in psychosis is crucial as they may precede treatment initiation and impact clinical outcomes. The neutrophil-to-lymphocyte ratio (NLR) serves as a potential marker of systemic inflammation.

Data Highlights

No significant differences in NLR were observed between FEP, CHR-P, and HC groups (F = 1.04; p=0.36).

Key Findings

  • No significant differences in NLR among FEP, CHR-P, and HC groups.
  • In FEP, NLR positively correlated with higher levels of positive symptoms (b2=0.035; p=0.01).
  • In FEP, NLR positively correlated with longer duration of untreated psychosis (b2=0.003; p=0.04).
  • In CHR-P, NLR negatively correlated with antidepressant use (b2=-0.664; p=0.02).
  • No significant associations between NLR and neurocognitive performance or antipsychotic treatment in any group.

Clinical Implications

The findings suggest that while NLR may not serve as a diagnostic biomarker in early psychosis, it could reflect inflammatory status related to symptom severity in FEP. Further research is warranted to explore the dynamics of NLR in larger samples.

Conclusion

The study indicates that NLR does not differentiate between psychosis stages but may correlate with symptom severity in FEP. Continued investigation into NLR's role in psychosis is necessary.

Related Resources & Content

  1. BMC Psychiatry (Springer), 2025 -- Gender-specific relationships between Neutrophil-Percentage-to-Albumin Ratio (NPAR) and Neutrophil-to-Lymphocyte Ratio (NLR) in relation to positive and negative symptoms in schizophrenia
  2. the pathologist, 2026 -- Can a Blood Count Predict Dementia?
  3. BMC Psychiatry (Springer), 2025 -- Connections Between Oxidative Stress, Niacin Response, Cognitive Function, and Symptoms in Chronic Schizophrenia: A Case-Control Analysis
  4. European Journal of Preventive Cardiology -- Inflammation in the spotlight: neutrophil-to-lymphocyte ratio takes centre stage in atherosclerotic cardiovascular disease
  5. Pharmacological and Somatic Treatments for First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines
  6. Targeting Psychotic and Cognitive Dimensions in Clinical High Risk for Psychosis (CHR-P): A Narrative Review | MDPI
  7. Frontiers | Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study
  8. Pharmacological and Somatic Treatments for First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines
  9. Targeting Psychotic and Cognitive Dimensions in Clinical High Risk for Psychosis (CHR-P): A Narrative Review | MDPI
  10. Frontiers | Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study

Original Source(s)

Related Content